Results 41 to 50 of about 5,540,950 (140)
Teprotumumab in advanced reactivated thyroid eye disease
American Journal of Ophthalmology Case Reports, 2022 Purpose: To report the case of a patient with reactivated, refractory thyroid eye disease (TED) treated with teprotumumab. Observations: A 51-year-old female with a 16-year history of thyroid eye disease previously treated with orbital decompression and ...
Olivia T. Cheng, Dianne M. Schlachter
doaj +1 more source
The thyrotropin receptor in thyroid eye disease
, 1998 Thyroid eye disease (TED) has an autoimmune etiology, but the nature of the autoantigen that is the target of the initiating event remains unknown. A number of candidates have been proposed based on Western blotting, library screening, and deduction from
Daumerie, Chantal +8 more
core +1 more source
Teprotumumab, New Era for Thyroid Eye Disease
, 2022 Thyroid eye disease is a progression of an autoimmune disease called Graves disease, which majorly affects eye orbits and its muscular tissues. It affects the patients by acting a impact on their quality of life by acting on patients visual balance along
Kale Rohit, Shrikant Solnake*
core +1 more source
Thyroid Orbitopathy and Dry Eye
, 2011 Thyroid orbitopathy (TO) is an inflammatory autoimmune disease of the orbital and periorbital tissues that is characterized by the presence of autoantibodies against thyroid-stimulating hormone receptor (TSH-R).
Canan Gürdal, Özge Saraç
core +1 more source
Медицинская иммунология, 2017 We searched for a possible target tissue in eye orbit for thyroid autoantibodies in endocrine ophthalmopathy (Graves’ disease), using correlation analysis method. We examined a group of 139 patients (278 eye orbits) with thyroid-associated ophthalmopathy
V. G. Likhvantseva +4 more
doaj +1 more source
An overview of thyroid eye disease
Eye and Vision, 2014 Thyroid eye disease (also known as Graves' ophthalmopathy) is a complex orbital inflammatory disease, which can be sight threatening, debilitating and disfiguring. This overview discusses the epidemiology, risk factors, pathogenesis, presentation, ophthalmic clinical features, investigations and treatment of thyroid eye disease.
openaire +2 more sources
Methotrexate for the Treatment of Thyroid Eye Disease [PDF]
Journal of Ophthalmology, 2014 Background/Aim. To evaluate the efficacy of methotrexate for the treatment of thyroid eye disease (TED).Methods. 36 consecutive patients with active TED, previously treated with corticosteroids but stopped due to the occurrence of side effects, were commenced on methotrexate therapy.
STRIANESE, DIEGO +11 more
openaire +5 more sources
Retrospective Review of Pediatric Thyroid Eye Disease Cases Referred to Nicklaus Children’s Hospital
The Pan-American Journal of Ophthalmology, 2018 Purpose: We evaluate presenting features and treatment options of pediatric thyroid eye disease, and discuss the morbidity of this condition in the pediatric population.
M Enghelberg +3 more
doaj
Isolated Superior Oblique Muscle Swelling Causing Acute Vertical Strabismus in Graves’ Disease
Case Reports in Ophthalmological Medicine, 2020 Purpose. To report a case of isolated superior oblique muscle swelling causing acute vertical strabismus in Graves’ disease. Case. A 26-year-old woman with a 1-month history of misalignment of the right eye and diplopia was referred to us.
Keiichi Aomatsu, Shunji Kusaka
doaj +1 more source
External radiotherapy of thyroid cancer [PDF]
, 2001 Differentiated thyroid cancer comprises papillary, mixed papillary-follicular and follicular adenocarcinomas. They are mostly hormone-sensitive and respond to thyroid-stimulating hormone (TSH) suppression. The standard treatment is total thyroidectomy. I-
Pollinger, B., Dühmke, Eckhart
core +1 more source